PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27166928-6	2016	In addition, EPA and DHA enhanced the expression of leptin, adiponectin and apelin genes only in young cells.	Eicosapentaenoic Acid	13-16	adiponectin, C1Q and collagen domain containing	Mus musculus	60-71	
30538803-9	2018	The DHA/EPA 2 : 1 group had lower serum levels of total cholesterol, triglycerides, and low-density lipoprotein cholesterol and higher levels of adiponectin than HFD group.	Eicosapentaenoic Acid	8-11	adiponectin, C1Q and collagen domain containing	Mus musculus	145-156	
23550153-10	2013	Consumption of EPA dramatically reduced serum leptin (P < 0.02) and increased serum adiponectin in the AL-EPA mice compared with AL-Con mice (P < 0.001).	Eicosapentaenoic Acid	15-18	adiponectin, C1Q and collagen domain containing	Mus musculus	87-98	
25816330-8	2015	Moreover, EPA treatment increased the otherwise reduced serum concentrations of adiponectin, an adipocytokine with anti-inflammatory and anti-fibrotic properties.	Eicosapentaenoic Acid	10-13	adiponectin, C1Q and collagen domain containing	Mus musculus	80-91	
17569885-3	2007	METHODS AND RESULTS: We demonstrated that EPA increases adiponectin secretion in genetically obese ob/ob mice and high-fat diet-induced obese mice.	Eicosapentaenoic Acid	42-45	adiponectin, C1Q and collagen domain containing	Mus musculus	56-67	
19277604-8	2009	RESULTS: DHA/EPA and rosiglitazone exerted additive effects in prevention of obesity, adipocyte hypertrophy, low-grade adipose tissue inflammation, dyslipidaemia and insulin resistance, while inducing adiponectin, suppressing hepatic lipogenesis and decreasing muscle ceramide concentration.	Eicosapentaenoic Acid	13-16	adiponectin, C1Q and collagen domain containing	Mus musculus	201-212	
17717684-7	2008	The same reduction in levels of adiponectin gene expression was observed in epididymal adipose tissue of animals chronically fed soybean and coconut diets and in 3T3-L1 cells treated with palmitic, linoleic, EPA, and DHA acids.	Eicosapentaenoic Acid	208-211	adiponectin, C1Q and collagen domain containing	Mus musculus	32-43	
23734181-0	2013	The eicosapentaenoic acid metabolite 15-deoxy-delta(12,14)-prostaglandin J3 increases adiponectin secretion by adipocytes partly via a PPARgamma-dependent mechanism.	Eicosapentaenoic Acid	4-25	adiponectin, C1Q and collagen domain containing	Mus musculus	86-97	
23734181-3	2013	In our study, we show that eicosapentaenoic acid (EPA) increases secreted adiponectin from 3T3-L1 adipocytes and in plasma of mice as early as 4 days after initiation of an EPA-rich diet.	Eicosapentaenoic Acid	27-48	adiponectin, C1Q and collagen domain containing	Mus musculus	74-85	
23734181-3	2013	In our study, we show that eicosapentaenoic acid (EPA) increases secreted adiponectin from 3T3-L1 adipocytes and in plasma of mice as early as 4 days after initiation of an EPA-rich diet.	Eicosapentaenoic Acid	50-53	adiponectin, C1Q and collagen domain containing	Mus musculus	74-85	
20861209-7	2010	Further, plasma adiponectin concentration was lower in the HF group but was comparable in the LF and HF-EPA groups, suggesting a role of EPA in preventing and improving insulin resistance induced by HF feeding.	Eicosapentaenoic Acid	137-140	adiponectin, C1Q and collagen domain containing	Mus musculus	16-27	
19416647-8	2009	When eicosapentaenoic acid (EPA), a suppressor of sterol regulatory element binding protein 1 (SREBP-1), was administered to HFHSD-fed mice, the sensitivity of DGalN, as a result of plasma ALT and AST levels, was suppressed accompanied by reduced plasma sTNFR2 level and hepatic levels of triglyceride, ROS, and fibrogenic parameters, and by increased plasma adiponectin levels.	Eicosapentaenoic Acid	5-26	adiponectin, C1Q and collagen domain containing	Mus musculus	359-370	
19416647-8	2009	When eicosapentaenoic acid (EPA), a suppressor of sterol regulatory element binding protein 1 (SREBP-1), was administered to HFHSD-fed mice, the sensitivity of DGalN, as a result of plasma ALT and AST levels, was suppressed accompanied by reduced plasma sTNFR2 level and hepatic levels of triglyceride, ROS, and fibrogenic parameters, and by increased plasma adiponectin levels.	Eicosapentaenoic Acid	28-31	adiponectin, C1Q and collagen domain containing	Mus musculus	359-370	
16397791-8	2006	EPA/DHA increased plasma adiponectin levels, independent of food intake, reflecting the stimulation of Adipoq expression in adipocytes and the release of adiponectin from WAT, particularly from epididymal fat.	Eicosapentaenoic Acid	0-3	adiponectin, C1Q and collagen domain containing	Mus musculus	25-36	
16397791-2	2006	We tested whether the anti-diabetic effects of EPA and DHA involve enhanced production of the endogenous insulin sensitiser, adiponectin.	Eicosapentaenoic Acid	47-50	adiponectin, C1Q and collagen domain containing	Mus musculus	125-136	
16397791-8	2006	EPA/DHA increased plasma adiponectin levels, independent of food intake, reflecting the stimulation of Adipoq expression in adipocytes and the release of adiponectin from WAT, particularly from epididymal fat.	Eicosapentaenoic Acid	0-3	adiponectin, C1Q and collagen domain containing	Mus musculus	103-109	
16397791-8	2006	EPA/DHA increased plasma adiponectin levels, independent of food intake, reflecting the stimulation of Adipoq expression in adipocytes and the release of adiponectin from WAT, particularly from epididymal fat.	Eicosapentaenoic Acid	0-3	adiponectin, C1Q and collagen domain containing	Mus musculus	154-165	
16397791-10	2006	CONCLUSIONS/INTERPRETATION: Intake of diets rich in EPA and DHA leads to elevated systemic concentrations of adiponectin, largely independent of food intake or adiposity and explain, to some extent, their anti-diabetic effects.	Eicosapentaenoic Acid	52-55	adiponectin, C1Q and collagen domain containing	Mus musculus	109-120